Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors

Authors:

Abstract
Chemotherapy-induced nausea and vomiting (CINV) is common among cancer patients. Early identification of patients at risk for CINV may help to personalize anti-emetic therapies. To date, few studies have examined the combined contributions of patient-reported and genetic risk factors to CINV. The goal of this study was to evaluate these risk factors.
Funding Information
  • National Cancer Institute (P30 CA076292)

This publication has 30 references indexed in Scilit: